Dementias Completed Phase 4 Trials for Galantamine (DB00674)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00299676An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period
NCT00814658The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of LifeTreatment
NCT01009476Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine